# Klisyri

NDC: 16110-391
Generic name: tirbanibulin
Labeler / Manufacturer: Almirall, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: OINTMENT
Routes: TOPICAL
Marketing started: 20201214

FDA application: NDA213189

## Active ingredients

- TIRBANIBULIN: 10 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16110-391"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16110-391
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=589c8de8-b773-4d47-b60c-48471806cccc